Design, synthesis, and activity of a novel series of factor Xa inhibitors: optimization of arylamidine groups.
Phillips G, Guilford WJ, Buckman BO, Davey DD, Eagen KA, Koovakkat S, Liang A, McCarrick M, Mohan R, Ng HP, Pinkerton M, Subramanyam B, Ho E, Trinh L, Whitlow M, Wu S, Xu W, Morrissey MM.
Phillips G, et al. Among authors: pinkerton m.
J Med Chem. 2002 Jun 6;45(12):2484-93. doi: 10.1021/jm0200660.
J Med Chem. 2002.
PMID: 12036356